Xylem (NYSE:XYL) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen downgraded shares of Xylem (NYSE:XYL) from a buy rating to a hold rating in a research report released on Saturday.

Several other brokerages have also recently weighed in on XYL. Barclays boosted their price target on shares of Xylem from $165.00 to $172.00 and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Cowen reiterated a “hold” rating on shares of Xylem in a report on Friday, December 5th. Royal Bank Of Canada increased their price target on shares of Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Zacks Research lowered shares of Xylem from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, November 18th. Finally, Citigroup increased their price objective on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday, October 29th. Eight research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $167.40.

Xylem Trading Up 0.1%

Shares of Xylem stock opened at $138.84 on Friday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.50. The stock’s 50 day simple moving average is $143.20 and its 200-day simple moving average is $139.85. The stock has a market cap of $33.80 billion, a P/E ratio of 35.69, a P/E/G ratio of 2.15 and a beta of 1.18. Xylem has a 1-year low of $100.47 and a 1-year high of $154.27.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.23 by $0.14. The firm had revenue of $2.27 billion during the quarter, compared to analysts’ expectations of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The business’s revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter last year, the firm earned $1.11 earnings per share. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Analysts predict that Xylem will post 4.65 EPS for the current fiscal year.

Xylem Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date was Tuesday, November 25th. Xylem’s dividend payout ratio is 41.13%.

Insiders Place Their Bets

In related news, Director Victoria D. Harker sold 1,700 shares of the business’s stock in a transaction on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total value of $251,838.00. Following the sale, the director owned 16,875 shares in the company, valued at approximately $2,499,862.50. The trade was a 9.15% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction dated Thursday, October 30th. The shares were sold at an average price of $152.64, for a total value of $1,590,661.44. Following the transaction, the executive vice president owned 31,250 shares of the company’s stock, valued at $4,770,000. This trade represents a 25.01% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. AIA Group Ltd boosted its position in Xylem by 335.1% in the 3rd quarter. AIA Group Ltd now owns 7,440 shares of the industrial products company’s stock valued at $1,097,000 after buying an additional 5,730 shares during the period. Keel Point LLC raised its stake in shares of Xylem by 4.6% in the third quarter. Keel Point LLC now owns 1,784 shares of the industrial products company’s stock valued at $263,000 after acquiring an additional 79 shares in the last quarter. Allworth Financial LP boosted its holdings in Xylem by 6.8% in the third quarter. Allworth Financial LP now owns 2,405 shares of the industrial products company’s stock valued at $355,000 after purchasing an additional 154 shares during the period. Swiss Life Asset Management Ltd grew its stake in Xylem by 7.5% during the 3rd quarter. Swiss Life Asset Management Ltd now owns 139,732 shares of the industrial products company’s stock worth $20,610,000 after purchasing an additional 9,800 shares in the last quarter. Finally, Cambria Investment Management L.P. increased its holdings in Xylem by 1.5% during the 3rd quarter. Cambria Investment Management L.P. now owns 10,066 shares of the industrial products company’s stock worth $1,485,000 after purchasing an additional 150 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.